Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Menapace LA"'
Publikováno v:
Current Opinion in Hematology; 2010 Sep, Vol. 17 Issue 5, p450-456, 7p
Autor:
Pipe SW M.D; University of Michigan, Ann Arbor, Michigan, United States., Lissitchkov TJ; SBALHZ EAD, Sofia, Bulgaria., Georgiev P; University Multiprofile Hospital for Active Treatment 'Sveti Georgi', Plovdiv, Clinic of Hematology and Medical University Plovdiv, Plovdiv,, Bulgaria., Mangles S; Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom., Hegemann I; University Hospital Zurich, Zurich, Switzerland., Trinchero A; University Hospital Zurich, Zurich, Switzerland., Chowdary P; Royal Free Hospital, London, United Kingdom., Forbes A; Royal Cornwall Hospital, Cornwall, United Kingdom., Feng L; Sanofi, Shanghai, China., Menapace LA; Sanofi, Cambridge, Massachusetts, United States., Kichou S; Sanofi, Paris, France., Andersson SR; Sanofi, Cambridge, MA, Cambridge, Massachusetts, United States., Demissie M; Sanofi, Cambridge, Massachusetts, United States., Ragni MV; University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.
Autor:
Xu JZ; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Conrey A; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Frey I; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Gwaabe E; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Menapace LA; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Tumburu L; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lundt M; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Lequang T; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Li Q; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Glass K; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Dunkelberger EB; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Iyer V; Agios Pharmaceuticals, Inc., Cambridge, MA., Mangus H; Agios Pharmaceuticals, Inc., Cambridge, MA., Kung C; Agios Pharmaceuticals, Inc., Cambridge, MA., Dang L; Agios Pharmaceuticals, Inc., Cambridge, MA., Kosinski PA; Agios Pharmaceuticals, Inc., Cambridge, MA., Hawkins P; Agios Pharmaceuticals, Inc., Cambridge, MA., Jeffries N; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Eaton WA; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Lay Thein S; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Publikováno v:
Blood [Blood] 2022 Nov 10; Vol. 140 (19), pp. 2053-2062.
Autor:
Menapace LA; Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Thein SL; Sickle Cell Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. sl.thein@nih.gov.
Publikováno v:
Haematologica [Haematologica] 2020 Nov 01; Vol. 105 (11), pp. 2501-2504. Date of Electronic Publication: 2020 Nov 01.
Autor:
Roydhouse JK; ORISE Fellow, Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration (US FDA), Silver Spring, MD, USA; Menzies Institute for Medical Research, University of Tasmania, Hobart TAS, Australia. Electronic address: jessica.roydhouse@utas.edu.au., Menapace LA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA., Xia H; Division of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Song P; Division of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Berman T; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Agarwal R; New Drug Products Branch II, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Suzman DL; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Wright K; Office of Prescription Drug Promotion, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA., Kluetz PG; Oncology Center of Excellence, US FDA, Silver Spring, MD, USA.
Publikováno v:
Complementary therapies in medicine [Complement Ther Med] 2020 Nov; Vol. 54, pp. 102549. Date of Electronic Publication: 2020 Aug 29.
Autor:
Roydhouse JK; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Menapace LA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Mishra-Kalyani PS; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Sridhara R; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Blumenthal GM; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
JAMA oncology [JAMA Oncol] 2019 Nov 01; Vol. 5 (11), pp. e192971. Date of Electronic Publication: 2019 Nov 14.
Autor:
Menapace LA; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA., McCrae KR; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA., Khorana AA; Taussig Cancer Institute, Department of Hematology Oncology, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: Khorana@ccf.org.
Publikováno v:
Thrombosis research [Thromb Res] 2016 Apr; Vol. 140 Suppl 1, pp. S93-8.
Autor:
Menapace LA; James P. Wilmot Cancer Center, and Department of Medicine, University of Rochester, Rochester, New York, USA., Peterson DR, Berry A, Sousou T, Khorana AA
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2011 Aug; Vol. 106 (2), pp. 371-8. Date of Electronic Publication: 2011 Jun 28.